In order to explore the role of PYCR1 in tumor cell resistance to cisplatin, lung adenocarcinoma cells in PYCR1-silenced/vector control/blank control groups were treated with cisplatin at different concentrations, followed by detection of inhibition of the proliferation using the CCK8 assay. The gene discussed is PYCR1; the disease is lung adenocarcinoma.